Finance

Beta
Lists
1228:HKG
Canbridge Pharmaceuticals Inc
HK$1.95
-2.01%
(-0.040) 1D
Jun 15, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1228...
Open
HK$1.99
High
HK$1.99
Low
HK$1.95
Mkt. cap
996.88M
Avg. vol.
804.56K
Volume
27.00K
52-wk high
HK$3.50
52-wk low
HK$0.25
Shares outstanding
8.19B
No. of employees
41
Open
HK$1.99
High
HK$1.99
Low
HK$1.95
Mkt. cap
996.88M
Avg. vol.
804.56K
Volume
27.00K
52-wk high
HK$3.50
52-wk low
HK$0.25
Shares outstanding
8.19B
No. of employees
41
News stories
From sources across the web
About Canbridge Pharmaceuticals Inc
CEO-
Employees41
Founded2012
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
11.12M
11.12M
13.87M
13.87M
Cost of goods sold
3.41M
3.41M
2.92M
2.92M
Cost of revenue
3.41M
3.41M
2.92M
2.92M
Research and development expenses
9.00M
9.00M
13.53M
13.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.65M
19.65M
22.45M
22.45M
Operating expense
28.65M
28.65M
35.98M
35.98M
Total operating expenses
32.06M
32.06M
38.90M
38.90M
Operating income
-20.94M
-20.94M
-25.03M
-25.03M
Other non operating income
450.50K
450.50K
-965.50K
-965.50K
EBT including unusual items
29.62M
29.62M
-22.21M
-22.21M
EBT excluding unusual items
-21.37M
-21.37M
-21.92M
-21.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
29.62M
29.62M
-22.21M
-22.21M
Net profit margin
266.26%
266.26%
-160.16%
-160.16%
Earnings per share
-
-
-
-
Interest and investment income
2.00K
2.00K
184.00K
184.00K
Interest expense
-884.50K
-884.50K
-230.50K
-230.50K
Net interest expenses
-882.50K
-882.50K
-46.50K
-46.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.18M
-18.18M
-22.32M
-22.32M
Gain or loss from assets sale
-50.99M
-50.99M
-78.50K
-78.50K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more